NMRA - Neumora Therapeutics, Inc. Common Stock

Price Target Consensus

7

Consensus Target

8

High Target

7

Median Target

6

Low Target

Price Target News & Updates

Date	Analyst	Company	Price Target	News Title
2026-01-05	Graig Suvannavejh	Mizuho Securities	$6	Neumora Therapeutics (NMRA) PT Raised to $6 at Mizuho
2025-12-01	N/A	RBC Capital	$7	Neumora Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
2025-10-28	N/A	Needham	$8	Neumora Therapeutics price target raised to $8 from $6 at Needham
2025-03-07	N/A	Stifel Nicolaus	$2	Neumora Therapeutics downgraded to Hold from Buy at Stifel
2025-01-02	Brian Abrahams	RBC Capital	$4	RBC Capital Downgrades Neumora Therapeutics (NMRA) to Sector Perform
2024-07-22	Ami Fadia	Needham	$23	Neumora Therapeutics initiated with a Buy at Needham
2024-07-08	Graig Suvannavejh	Mizuho Securities	$20	Neumora Therapeutics initiated with an Outperform at Mizuho
2024-06-17	Brian Abrahams	RBC Capital	$29	RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
2024-03-13	Brian Abrahams	RBC Capital	$31	RBC Capital Out Positive on Neumora Therapeutics (NMRA): ' See Compelling Entry…
2023-10-10	Brian Abrahams	RBC Capital	$24	Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder D…